Zydus, Takeda Tell 3rd Circ. Antitrust Appeal In Right Place
Zydus Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. have told the Third Circuit that Zydus' bid to revive antitrust counterclaims should not be moved to the Federal Circuit because patent infringement...To view the full article, register now.
Already a subscriber? Click here to view full article